Somatic Genitourinary Cancer Taskforce
The Genitourinary Cancer Taskforce will embark on variant curation for FGFR and PARP inhibitor pathways, using Clinical Interpretations of Variants in Cancer (CIViC) platform for variant curation. The somatic variants should be examined and curated for the clinical significance/clinical management of patients, i.e. their role in the diagnosis, prognosis, therapeutic outcomes, prevention of the disease, or disease surveillance.
The GU taskforce is currently accepting members to join the team and support its variant curation and interpretation activities.